Analysts' Actions: BA, MCD, HES, NFLX, DAL

Valeant Pharmaceuticals (VRX) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. Valuation call, based on a $54 price target.

WellPoint (WLP) downgraded at Jefferies to Hold from Buy, Jefferies said. $72 price target. Company miss will decrease target multiple.

STOCK COMMENTS / EPS CHANGES

Boeing (BA) estimates lowered at Citigroup through 2013, Citigroup said. Outlook for defense business is not as robust as originally forecast. Maintain Buy rating and $87 price target.

Peabody Energy (BTU) numbers lowered at Goldman. Shares of BTU now seen reaching $41, according to Goldman Sachs. Estimates also cut, given higher spending on Macarthur. Neutral rating.

Delta Air Lines (DAL) numbers raised at UBS. Shares of DAL now seen reaching $15. Estimates also increased on strong outlook. Buy rating.

Dover (DOV) estimates, target upped at Credit Suisse. DOV estimates were boosted through 2013, Credit Suisse said. Booking are stabilizing. Neutral rating and new $67 price target.

Corning (GLW) numbers cut at UBS. Shares of GLW now seen reaching $15, according to UBS. Estimates also lowered as near term catalysts remain elusive and fundamentals remain difficult. Buy rating.

WW Grainger (GWW) numbers boosted at Goldman. Shares of GWW now seen reaching $211, Goldman Sachs said. Estimates also upped, Revenue growth is accelerating. Neutral rating.

Hess (HES) estimates, target reduced at Goldman. HES estimates were cut through 2015, Goldman Sachs said. Company is facing higher costs. Neutral rating and new $66 price target.

Hess estimates, target lowered at UBS. Shares of HES now seen reaching $68, according to UBS. Estimates also lowered on 4Q miss and disappointing guidance. Buy rating.

Illumina (ILMN) target raised at UBS to $55 following Roche's hostile bid, UBS said. Maintain Neutral rating.

McDonald's (MCD) estimates, target raised at BMO. Shares of MCD now seen reaching $110, according to BMO Capital. Estimates also increased, given solid comp sales momentum. Market Perform rating.

Molex (MOLX) estimates, target cut at Goldman. Shares of MOLX now seen reaching $24.50, according to Goldman Sachs. Estimates also reduced, as the company is realizing lower margins. Neutral rating.

Netflix (NFLX) numbers raised at Oppenheimer. Shares of NFLX now seen reaching $130, Oppenheimer said. Estimates also raised on better than expected results. Outperform rating.

« First ‹ Previous 1 2 3 4 Next › Last »